Regulatory Affairs Team

The Regulatory Affairs Team at BridgeBio is responsible for overseeing the approval process of innovative therapies for genetic diseases. They ensure compliance with global regulatory requirements, manage submissions to health authorities, and facilitate communication between the company and regulatory agencies. Their expertise helps to streamline the development and commercialization of breakthrough medicines while maintaining high standards of safety and efficacy.